Pilar Goya Selected Research

PM226

1/2016

Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pilar Goya Research Topics

Disease

2	Neoplasms (Cancer) 11/2018 - 07/2016
2	Multiple Sclerosis 11/2018 - 01/2016
2	Obesity 04/2012 - 01/2008
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2018
1	Autoimmune Diseases (Autoimmune Disease) 11/2018
1	Huntington Disease (Huntington's Disease) 11/2018
1	Osteoporosis 11/2018
1	Ischemic Stroke 11/2018
1	Inflammation (Inflammations) 07/2016
1	Arthritis (Polyarthritis) 07/2016
1	Pain (Aches) 07/2016
1	Demyelinating Diseases (Demyelinating Disease) 01/2016
1	Chronic Progressive Multiple Sclerosis 01/2016
1	Triple Negative Breast Neoplasms 03/2015
1	Breast Neoplasms (Breast Cancer) 03/2015
1	Hyperphagia (Overeating) 01/2013
1	Prostatic Neoplasms (Prostate Cancer) 01/2013

Drug/Important Bio-Agent (IBA)

3	CannabinoidsIBA 01/2016 - 04/2012
2	CB2 Cannabinoid ReceptorIBA 11/2018 - 07/2016
2	Antineoplastic Agents (Antineoplastics)IBA 03/2015 - 01/2013
2	RimonabantIBA 01/2013 - 01/2008
1	PM226IBA 01/2016
1	IsoxazolesIBA 01/2016
1	quinone (benzoquinone)IBA 03/2015
1	GhrelinIBA 01/2013
1	Hormones (Hormone)IBA 01/2013
1	Cannabinoid Receptor AntagonistsIBA 04/2012

Therapy/Procedure

1	Pain Management 07/2016
1	Therapeutics 04/2012